metformin or semaglutide for weight loss Frontiers Is Metformin as Good as

These preclinical data suggest unimolecular poly-pharmacology as an effective means to target multiple mechanisms contributing to obesity, and further implicate glucagon receptor activation as the differentiating factor between incretin receptor mono- or dual-agonists and triagonists

About 68% of those who stuck with their treatment wound up with normal blood sugar levels, compared with 41% who stopped taking the drugs later in the study and 33% who stopped earlier

Many patients exploring semaglutide options lack clarity on pharmacy types, which directly affects treatment safety and efficacy

In September 2025, the FDA sent thousands of warning letters and issued approximately 100 cease-and-desist letters to companies regarding their use of misleading direct-to-consumer pharmaceutical advertisements. The agency also published a green list of acceptable GLP-1 compounding ingredients intended to regulate ingredient sourcing and reduce the risk of unsafe compounded products